Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Idania Baladrón"'
Autor:
Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Externí odkaz:
https://doaj.org/article/7fa9e2020e7f4dcf9cc2aaa835127a26
Autor:
Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, Yenima Martín-Bauta, Ernesto Rodríguez-Martínez, Klaudia Urrutia-Pérez, Karen Urrutia-Pérez, Joel Quintana-Guerra, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, José L. Rodríguez-Reinoso, Cristina O. Chávez-Chong, Idania Baladrón-Castrillo, Grettel Melo-Suárez, Alejandro Batista-Izquierdo, Alexis Pupo-Micó, Ricardo Mora-Betancourt, Jacqueline Bizet-Almeida, Maria C. Martínez-Rodríguez, Leonardo Lobaina-Lambert, Vivian M. Velázquez-Pérez, Jalimy Soler-Díaz, Sandra Laurencio-Vallina, Tamara Meriño-Hechavarría, Norberto Carmenaty-Campos, Enri Rodríguez-Montero, Miladys Limonta-Fernández, Marel Alonso-Valdés, Reinier Hernández-Rodríguez, Eulogio Pimentel-Vázquez, Karem M. Catasús-Álvarez, Maria V. Cabrera-Núñez, Marta Ayala-Ávila, Verena L. Muzio-González
Publikováno v:
The Lancet Regional Health - Americas. 21:100497
Autor:
Francisco Hernández-Bernal, Maria del Carmen Ricardo-Cobas, Yenima Martín-Bauta, Ernesto Rodríguez-Martínez, Klaudia Urrutia-Pérez, Karen Urrutia-Pérez, Joel Quintana-Guerra, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, José Luis Rodríguez-Reinoso, Cristina Olimpia Chávez-Chong, Idania Baladrón-Castrillo, Grettel Melo-Suárez, Alejandro Batista-Izquierdo, Alexis R. Pupo-Micó, Ricardo L. Mora-Betancourt, Dayamí Soler-Cano, Jacqueline Bizet-Almeida, Maria C. Martínez-Rodríguez, Leonardo Lobaina-Lambert, Vivian M. Velázquez-Pérez, Jalimy Soler-Díaz, Yunaili Blanco-Garrido, Sandra Laurencio-Vallina, Tamara Meriño-Hechavarría, Norberto Carmenaty-Campos, Enri Rodríguez-Montero, Miladys Limonta-Fernández, Marel A. Valdés, Reinier Hernández-Rodríguez, Eulogio Pimentel-Vázquez, Karem M. Catasús-Álvarez, Maria V. Cabrera-Núñez, Marta Ayala-Ávila, Verena L. Muzio-González, ABDALA Group of Investigators
Publikováno v:
SSRN Electronic Journal.
Autor:
Aliusha Rittoles, Maria M. Vazquez, Jesus Perez, Raul Santana, Ariel Gonzalez, Silvio E. Perea, Ralysmay Rodriguez, Leticia R. Cruz, Carmen Valenzuela, Yasser Perera, Rafael Reyes, Ailyn C. Ramón, Ariadna Garcia, Gerardo Guillén, Dania M Vázquez-Bloomquist, George V. Pérez, Verena Muzio, Pablo A. Diaz, Gustavo Perera, Delvin Thompson, Deyli Chacon, Yania Valido, Mauro Rosales, Idania Baladrón, Loida Torres
Publikováno v:
ACS Pharmacology & Translational Science
The instrumental role of CK2 in the SARS-CoV-2 infection has pointed out this protein kinase as promising therapeutic target in COVID-19. Anti-SARS-CoV-2 activity has been reported by CK2 inhibitors in vitro; however, no anti-CK2 clinical approach ha
Autor:
Loida Torres, Silvio E. Perea, Ariel Gonzalez, Ailyn C. Ramón, Gerardo Guillén, George V. Pérez, Dania M. Vazquez, Aliusha Rittoles, Maria M. Vazquez, Verena Muzio, Ariadna Garcia, Raul Santana, Carmen Valenzuela, Idania Baladrón, Gilda Lemus, Leticia R. Cruz, Rafael Reyes, Deyli Chacon, Mauro Rosales, Pablo A. Diaz, Gustavo Perera, Delvin Thompson, Yasser Perera, Jesus Perez
PurposeThe instrumental role of CK2 in the SARS-Cov2 infection has pointed out this protein kinase as a promising therapeutic target in Covid-19. Anti-SARS-Cov2 activity has been reported by CK2 inhibitors in vitro; however, any anti-CK2 clinical app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97b80ae8d46ff82ae46a952932c7fb1b
https://doi.org/10.1101/2020.09.03.20187112
https://doi.org/10.1101/2020.09.03.20187112
Autor:
Jesús A. Junco, Ranfis Rodríguez, Franklin Fuentes, Idania Baladrón, Maria D. Castro, Lesvia Calzada, Carmen Valenzuela, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Niurka Arteaga, Angel Cid-Arregui, Francisco Sariol, Lourdes González, Liliana Porres-Fong, María Medina, Ayni Rodríguez, A. Hilda Garay, Osvaldo Reyes, Matilde López, Lourdes de Quesada, Allelin Alvarez, Carolina Martínez, Marleny Marrero, Guillermo Molero, Alfredo Guerra, Pedro Rosales, Carlos Capote, Sahily Acosta, Idania Vela, Lina Arzuaga, Ana Campal, Erlán Ruiz, Elier Rubio, Pável Cedeño, María Carmen Sánchez, Pedro Cardoso, Rolando Morán, Yairis Fernández, Magalys Campos, Henio Touduri, Dania Bacardi, Indalecio Feria, Amilcar Ramirez, Karelia Cosme, Pedro López Saura, Maricel Quintana, Verena Muzio, Ricardo Bringas, Marta Ayala, Mario Mendoza, Luis E. Fernández, Adriana Carr, Luis Herrera, Gerardo Guillén
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Heberprovac is a GnRH based vaccine candidate containing 2.4 mg of the GnRHm1-TT peptide as the main active principle; 245 μg of the very small size proteoliposomes adjuvant (VSSP); and 350 μL of Montanide ISA 51 VG oil adjuvant. The aim of this st
Publikováno v:
Seminars in oncology. 45(1-2)
Protein kinase CK2, formerly referred to as casein kinase II, is a serine/threonine kinase often found overexpressed in solid tumors and hematologic malignancies that phosphorylates many substrates integral to the hallmarks of cancer. CK2 has emerged
Autor:
Daniel F. Alonso, Hilda Garay, Aley Palau, Silvio E. Perea, Arielis Rodriguez, Jorge L. Soriano, Aniel Sanchez, Margarita Solares, Hugo Sigman, Idania Baladrón, Idrian García García, Marisol Cruz, Lila Castellanos, Phillipe Perrin, Carmen Valenzuela, Ignacio Hernández, Roberto Gómez, Jean-Yves Renualt, Hernan G. Farina, M. López, Jeovanis Gil, Carlos Alonso González, Vladimir Besada, Daniel E. Gomez, Lazaro Betancourt, Luis Javier Herrera, Pedro Lopez-Saura, Alina Díaz, Yasser Perera, Adlin Lopez, A. E. G. Santana, N. Batista, Luis Javier González, Lidia González, Boris Acevedo, Osvaldo Reyes, Yanelda García
Publikováno v:
Molecular and Cellular Biochemistry. 356:45-50
CK2 represents an oncology target scientifically validated. However, clinical research with inhibitors of the CK2-mediated phosphorylation event is still insufficient to recognize it as a clinically validated target. CIGB-300, an investigational pept
Autor:
Milaid Granadillo, Aileen Batte, Thelvia Ramos, Isis Torrens, Zaida Borbon, Sonia Fanjull, María E. Fernández de Cossio, Idania Baladrón, Julio Esmir, Mayte Ale, Alberto Cintado, Leonardo Gonzalez, Ana M. Solares, Pedro Lopez-Saura, Carmen Valenzuela, Dagnelia Castillo, Annia Ferrer
Publikováno v:
ISRN Obstetrics and Gynecology
Objective. CIGB-228 is a novel therapeutic vaccine consisting of HLA-restricted HPV16 E7 epitope adjuvated with VSSP. This trial was designed to evaluate the toxicity, safety, immunogenicity, HPV clearance, and lesion regression. Methods. Seven women
Autor:
Yaquelin Puchades, Hugo Sigman, Jose Luis Marcelo, Yasser Perera, Dania Bacardí, Idania Baladrón, Daniel E. Gomez, Silvio E. Perea, Lazaro Betancourt, Luis Javier Herrera, Marisol Cruz, Karelia Cosme, Arielis Rodriguez, Osmani Mendoza, A. E. G. Santana, Aniel Sanchez, Carmen Valenzuela, Ignacio Hernández, Roberto E. Gómez, Juan Ariosa, Lila Castellanos, Hilda Garay, Thelvia Ramos, Vladimir Besada, Daniel F. Alonso, Jeovanis Gil, Joem M. Serrano, Carlos López, Osvaldo Reyes, Luis Javier González, Alina Díaz, Ricardo Silva, Boris Acevedo, Viviana Falcón, Hernan G. Farina, Ernesto López, Margarita Solares, Pedro Lopez-Saura
Publikováno v:
Molecular and Cellular Biochemistry. 316:163-167
Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, we hypothesized that a peptide binder to the CK2 phosphoacceptor site could exhibit anticancer properties in vitro, in tumor animal models, and in canc